JP Morgan Chase
ARRY

JP Morgan Chase’s Array Biopharma Inc ARRY Stock Holding History

JP Morgan Chase’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,462,833
Closed -$67.6M – 6140
2019
Q2 		$67.6M Buy
1,462,833
+115,605
+9% +$3.25M 0.01% 826
2019
Q1 		$32.8M Buy
1,347,228
+1,167,922
+651% +$24.3M 0.01% 1198
2018
Q4 		$2.56M Buy
179,306
+6,096
+4% +$92.5K ﹤0.01% 3111
2018
Q3 		$2.63M Buy
173,210
+126,498
+271% +$1.94M ﹤0.01% 3260
2018
Q2 		$784K Buy
46,712
+2,521
+6% +$40.1K ﹤0.01% 3953
2018
Q1 		$721K Sell
44,191
-2,284
-5% -$36.6K ﹤0.01% 3847
2017
Q4 		$595K Sell
46,475
-233,289
-83% -$2.65M ﹤0.01% 3993
2017
Q3 		$3.43M Buy
+279,764
New +$2.6M ﹤0.01% 2834
2017
Q1 		– Sell
-210,250
Closed -$2.24M – 5339
2016
Q4 		$1.85M Sell
210,250
-6,933
-3% -$51K ﹤0.01% 3118
2016
Q3 		$1.47M Buy
217,183
+214,183
+7,139% +$828K ﹤0.01% 2958
2016
Q2 		$11K Buy
+3,000
New +$9.78K ﹤0.01% 4333
2016
Q1 		– Sell
-8,876
Closed -$37K – 5084
2015
Q4 		$37K Sell
8,876
-4,424
-33% -$20.2K ﹤0.01% 3979
2015
Q3 		$61K Hold
13,300
– – ﹤0.01% 3783
2015
Q2 		$96K Sell
13,300
-149,051
-92% -$1.1M ﹤0.01% 3885
2015
Q1 		$1.2M Buy
162,351
+148,751
+1,094% +$1.06M ﹤0.01% 3139
2014
Q4 		$64K Buy
+13,600
New +$53.8K ﹤0.01% 4133
2014
Q2 		– Sell
-11,312
Closed -$54K – 3675
2014
Q1 		$54K Sell
11,312
-1,800
-14% -$9.05K ﹤0.01% 3513
2013
Q4 		$66K Sell
13,112
-57,661
-81% -$314K ﹤0.01% 3956
2013
Q3 		$440K Sell
70,773
-56,054
-44% -$333K ﹤0.01% 3693
2013
Q2 		$576K Buy
+126,827
New +$682K ﹤0.01% 3534

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

JP Morgan Chase's ARRY Position: Q3 2019 in Review

JP Morgan Chase sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 1,462,833 shares — an estimated $67.6M sold.

JP Morgan Chase first reported a position in ARRY in Q2 2013 and held it in 20 quarters. The position peaked at $67.6M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • JP Morgan Chase reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • JP Morgan Chase sold 1,462,833 Array Biopharma Inc shares in Q3 2019, an estimated $67.6M.
  • JP Morgan Chase first reported a position in Array Biopharma Inc in Q2 2013 and held it in 20 quarters.
  • JP Morgan Chase's Array Biopharma Inc position peaked at $67.6M in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on JP Morgan Chase's 13F filing for Q3 2019, filed 12 Nov 2019.